CDKN2A Antibody

Contact us
ProSci
Product Code: PSI-4211
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-4211-0.02mg0.02mg£150.00
Quantity:
PSI-4211-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence (IF)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)

Images

1 / 12
<strong>Figure 1 KO Validation of CDKN2A in 293 Cells</strong><br> Loading: 10 μg of 293 WT cell lysates or CDKN2A KO cell lysates. Antibodies: CDKN2A 4211 (2 μg/mL) and beta-actin 3779 (1 μg/mL) 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.
2 / 12
<strong>Figure 2. Immunofluorescence Validation of CDKN2A In HeLa Cells </strong><br> Immunofluorescent analysis of methanol-fixed HeLa cells labeling CDKN2A with 4211 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/1000 dilution (red) and Hoechst staining (blue). Alpha tubulin was stained with anti-alpha tubulin antibody following by goat anti-mouse IgG secondary antibody (green). Images were captured with confocal microscopy.
3 / 12
<strong>Figure 3 Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines</strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (4 μg/mL) CDKN2A 24-023 (4 μg/mL) and beta-actin (1 μg/mL) overnight incubation at 4˚C in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
4 / 12
<strong>Figure 4 Recombinant Protein Test</strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (2 μg/mL) overnight incubation at 4˚C in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: Human prostate (benign hyperplasia)Lane 2: Human CDKN2A recombinant protein (arrow: monomer and dimer)
5 / 12
<strong>Figure 5 Western Blot Validation in Human Cell Lines</strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (2 μg/mL) 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
6 / 12
<strong>Figure 6 Western Blot Validation in Human Normal and Cancer Tissue</strong><br>Loading: 15 μg of lysates per lane.Antibodies CDKN2A 4211 (2 μg/mL) overnight incubation at 4˚C in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: Human breastLane 2: Human lung tumorLane 3: Human colon cancer
7 / 12
<strong>Figure 7 Western Blot Validation in Mouse Colon Tissue </strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (A: 1 μg/mL B: 2 μg/mL) 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
8 / 12
<strong>Figure 8 Immunofluorescence Validation of CDKN2A in Human A431 Cells</strong><br>Immunofluorescent analysis of 4% paraformaldehyde-fixed A431 cells labeling CDKN2A with 4211 at 20 μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
9 / 12
<strong>Figure 9 Immunofluorescence Validation of CDKN2A in Human Colon Tissue</strong><br>Immunofluorescent analysis of 4% paraformaldehyde-fixed human colon tissue labeling CDKN2A with 4211 at 20 μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
10 / 12
<strong>Figure 10 Immunofluorescence Validation of CDKN2A in Rat Colon Tissue</strong><br>Immunofluorescent analysis of 4% paraformaldehyde-fixed Rat Colon Tissue labeling CDKN2A with 4211 at 20 μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).
11 / 12
<strong>Figure 11 Immunohistochemistry Validation of CDKN2A in Human Colon Tissue </strong><br> Immunohistochemical analysis of paraffin-embedded Human Colon Tissue using anti- CDKN2A antibody (4211) at 10 μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
12 / 12
<strong>Figure 12 Immunohistochemistry Validation of CDKN2A in Rat Colon Tissue </strong><br> Immunohistochemical analysis of paraffin-embedded Rat Colon Tissue using anti- CDKN2A antibody (4211) at 5 μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
❮❯

<strong>Figure 1 KO Validation of CDKN2A in 293 Cells</strong><br> Loading: 10 μg of 293 WT cell lysates or CDKN2A KO cell lysates. Antibodies: CDKN2A 4211 (2 μg/mL) and beta-actin 3779 (1 μg/mL) 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.
<strong>Figure 2. Immunofluorescence Validation of CDKN2A In HeLa Cells </strong><br> Immunofluorescent analysis of methanol-fixed HeLa cells labeling CDKN2A with 4211 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/1000 dilution (red) and Hoechst staining (blue). Alpha tubulin was stained with anti-alpha tubulin antibody following by goat anti-mouse IgG secondary antibody (green). Images were captured with confocal microscopy.
<strong>Figure 3 Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines</strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (4 μg/mL) CDKN2A 24-023 (4 μg/mL) and beta-actin (1 μg/mL) overnight incubation at 4˚C in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
<strong>Figure 4 Recombinant Protein Test</strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (2 μg/mL) overnight incubation at 4˚C in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: Human prostate (benign hyperplasia)Lane 2: Human CDKN2A recombinant protein (arrow: monomer and dimer)
<strong>Figure 5 Western Blot Validation in Human Cell Lines</strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (2 μg/mL) 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
<strong>Figure 6 Western Blot Validation in Human Normal and Cancer Tissue</strong><br>Loading: 15 μg of lysates per lane.Antibodies CDKN2A 4211 (2 μg/mL) overnight incubation at 4˚C in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: Human breastLane 2: Human lung tumorLane 3: Human colon cancer
<strong>Figure 7 Western Blot Validation in Mouse Colon Tissue </strong><br>Loading: 15 μg of lysates per lane.Antibodies: CDKN2A 4211 (A: 1 μg/mL B: 2 μg/mL) 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
<strong>Figure 8 Immunofluorescence Validation of CDKN2A in Human A431 Cells</strong><br>Immunofluorescent analysis of 4% paraformaldehyde-fixed A431 cells labeling CDKN2A with 4211 at 20 μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
<strong>Figure 9 Immunofluorescence Validation of CDKN2A in Human Colon Tissue</strong><br>Immunofluorescent analysis of 4% paraformaldehyde-fixed human colon tissue labeling CDKN2A with 4211 at 20 μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
<strong>Figure 10 Immunofluorescence Validation of CDKN2A in Rat Colon Tissue</strong><br>Immunofluorescent analysis of 4% paraformaldehyde-fixed Rat Colon Tissue labeling CDKN2A with 4211 at 20 μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).
<strong>Figure 11 Immunohistochemistry Validation of CDKN2A in Human Colon Tissue </strong><br> Immunohistochemical analysis of paraffin-embedded Human Colon Tissue using anti- CDKN2A antibody (4211) at 10 μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
<strong>Figure 12 Immunohistochemistry Validation of CDKN2A in Rat Colon Tissue </strong><br> Immunohistochemical analysis of paraffin-embedded Rat Colon Tissue using anti- CDKN2A antibody (4211) at 5 μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Documents

Further Information

Additional Names:
CDKN2A Antibody: ARF, MLM, P14, P16, P19, CMM2, INK4, MTS1, TP16, CDK4I, CDKN2, INK4A, MTS-1, P19ARF, P16INK4, P16INK4A, P16-INK4A, Cyclin-dependent kinase 4 inhibitor A
Application Note:
WB: 1 - 4 μg/mL; IHC-P: 5 - 10 μg/mL; IF: 20 μg/mL.

Antibody validated: Western Blot in human and mouse samples; Immunohistochemistry in human and rat samples; Immunofluorescence in human and rat samples. All other applications and species not yet tested.
Background:
CDKN2A Antibody: The CDKN2A locus gives rise to 2 distinct transcripts from different promoters. The transcripts have been designated p16(INK4A) and p14(ARF). This chromosomal region undergoes a number of inversions, translocations, heterozygous deletions, and homozygous deletions in a variety of malignant cell lines including those from glioma, non-small cell lung cancer, leukemia, and melanoma. Deletion of the region containing CDKN2A is found in more than half of all melanoma cell lines. Conversely, transfection of CDKN2A suppressed the growth of two independent mesothelioma cell lines, suggesting that inactivation of the CDKN2 gene is an essential step in the etiology of malignant mesotheliomas. CDKN2A induces a G1 cell cycle arrest by inhibiting the phosphorylation of the Rb protein by the cyclin-dependent kinases CDK4 and CDK6. CDKN2A is expressed as at least three distinct isoforms.
Background References:
  • Stone et al. Cancer Res. 1995; 55:2988-94.
  • Kamb et al. Nature Genet. 1994; 8:22-6.
  • Kratzke et al. J. Nat. Cancer Inst. 1995; 87:1870-5.
  • Stott et al. EMBO J. 1998; 17:5001-14.
Buffer:
CDKN2A Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Anti-CDKN2A antibody (4211) was raised against a peptide corresponding to 18 amino acids near the amino terminus of human CDKN2A.

The immunogen is located within the first 50 amino acids of CDKN2A.
ISOFORMS:
Human CDKN2A has 6 isoforms, including isoform 1 (156aa, 17kD), isoform 2 (105aa, 11kD), isoform 3 (116aa, 12kD), isoform 5 (167aa, 18kD), isoform tumor suppressor ARF (132aa, 14kD) and isoform smARF (85aa, 9kD). Mouse CDKN2A has 4 isoforms, including isoform 1 (168aa, 18kD), isoform 2 (125aa, 14kD), isoform tumor suppressor ARF (169aa, 19kD) and isoform smARF (125aa, 14kD). Rat CDKN2A has two isoforms, including isoform 1 (159aa, 17kD) and isoform ARF (160aa, 17kD). 4211 can detect only human isoforms 1, 3 and 5, mouse isoform 1 and rat isoform 1.
NCBI Gene ID #:
1029
NCBI Official Name:
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
NCBI Official Symbol:
CDKN2A
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
Predicted: 17 kDa

Observed: 17 kDa
Protein Accession #:
NP_000068
Protein GI Number:
4502749
Purification:
CDKN2A Antibody is affinity chromatography purified via peptide column.
Research Area:
Signal Transduction,Homeostasis,Cancer
Swissprot #:
P42771
User NOte:
Optimal dilutions for each application to be determined by the researcher.
VALIDATION:

KO Validation (Figure 1): Anti-CDKN2A antibodies (4211) specificity was further verified by CDKN2A specific knockout. CDKN2A signal was not detected in CDKN2A knockout 293 cells as compared to that in control wild type cells.

Independent Antibody Validation in Cell lines (Figure 2) shows similar CDKN2A expression profile in human cell lines detected by two independent anti-CDKN2A antibodies that recognize different epitopes, 4211 against N-terminus domain and 8975 against the C-terminus domain.  CDKN2A proteins are detected only in 293, HeLa and HepG2 cell lines by the two independent antibodies. 

Recombinant Protein Test (Figure 3) shows that anti-CDKN2A antibody (4211) detects human recombinant CDKN2A protein that contains the amino acids of 4211 antigenic peptide.

Related Products

Product NameProduct CodeSupplier 
CDKN2A PeptidePSI-4211PProSci Summary Details